Slow Capital, Inc. Abb Vie Inc. Transaction History

Slow Capital, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $339,848 - $421,656	-2,575 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $214 - $271	2 Added 0.08%	2,575 $349,000
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $5,213 - $5,918	-49 Reduced 1.87%	2,573 $278,000
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $4,103 - $4,571	39 Added 1.51%	2,622 $295,000
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $16,163 - $17,793	158 Added 6.52%	2,583 $279,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $33,483 - $45,206	416 Added 20.71%	2,425 $260,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $43,040 - $50,515	-501 Reduced 19.96%	2,009 $176,000
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $16,068 - $21,501	-219 Reduced 8.02%	2,510 $246,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $21,349 - $32,368	331 Added 13.8%	2,729 $208,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $172,967 - $216,419	2,398 New	2,398 $212,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.